Company Description At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re
Salary Range:CHF102,200.00 - CHF189,800.00 Job Description SummaryJob Title: Senior Expert (AI Engineering) #LI-Hybrid Location: Basel, Switzerland Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to offer relocation support: please only apply if
Company Description At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Job Description Key Responsibility The Indirect sourcing manager supports internal stakeholders in the procurement process to ensure cost efficient, time efficient, and compliant purchases. Perform cost and scenario analysis and benchmarking, including identifying savings and optimization opportunities
Overview PM Group is a leading International engineering, architecture, project and construction management firm. With a network of offices in Europe, Asia and the US and a multi-discipline team of 4,000+ people, we deliver complex, capital
At Roche/Genentech Pharma Product Development Global Clinical Operations (PDG), we are determined to transform drug development and realize our Pharma Ambition to deliver 20 transformative medicines addressing diseases with the highest societal burden by 2029. We